Compare AQB & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AQB | NUWE |
|---|---|---|
| Founded | 1991 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 2.9M |
| IPO Year | N/A | N/A |
| Metric | AQB | NUWE |
|---|---|---|
| Price | $0.88 | $2.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.6K | ★ 6.4M |
| Earning Date | 03-26-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,167,999.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $1.71 |
| 52 Week High | $2.95 | $62.16 |
| Indicator | AQB | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 43.50 |
| Support Level | $0.78 | $2.42 |
| Resistance Level | $1.01 | $4.47 |
| Average True Range (ATR) | 0.08 | 0.61 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 30.39 | 7.36 |
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.